A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy.

Saved in:
Bibliographic Details
Title: A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy.
Authors: Hino K; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.; Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, 160 Kou, Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan., Nishina T; Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, 160 Kou, Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan. nishina.tomohiro.nj@mail.hosp.go.jp., Koizumi M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan., Marui K; Endoscopy Center, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan., Kokubu M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan., Numata Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan., Imamura Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan., Kanemitsu-Okada K; Department of Gastroenterology, Ehime Prefectural Central Hospital, 83 Kasuga-Machi, Matsuyama, Ehime, 790-0024, Japan., Otsuru T; Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, 160 Kou, Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan., Kuroda T; Department of Gastroenterology, Ehime Prefectural Central Hospital, 83 Kasuga-Machi, Matsuyama, Ehime, 790-0024, Japan., Ohno Y; Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, 160 Kou, Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan., Asagi A; Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, 160 Kou, Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan., Miyata H; Department of Gastroenterology, Ehime Prefectural Central Hospital, 83 Kasuga-Machi, Matsuyama, Ehime, 790-0024, Japan., Yokota T; Center for Liver-Biliary-Pancreatic Diseases, Matsuyama Red Cross Hospital, 1 Bunkyo-Cho, Matsuyama, Ehime, 790-8524, Japan., Kumagi T; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan., Hyodo I; Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, 160 Kou, Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan., Ikeda Y; Endoscopy Center, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan., Hiasa Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Source: International journal of clinical oncology [Int J Clin Oncol] 2025 Apr; Vol. 30 (4), pp. 738-748. Date of Electronic Publication: 2025 Feb 27.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first